ArticleRenal failure2025

Nafamostat mesylate versus regional citrate anticoagulation for chronic hemodialysis in patients at high risk of bleeding: a single-center, retrospective study.

Jiangtao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.